Reducing the Rebate Amount for Part B Rebatable Biosimilar Biological Products When There Is a Severe Supply Chain Disruption In 427.402 of this proposed rule, CMS proposes to codify the policy established in section 50.12 of the revised Medicare Part B Drug Inflation Rebate Guidance for rebate reductions when CMS determines there is a severe supply chain disruption during a calendar quarter
The funders of the study had no role in study design, data collection, data analysis, data interpretation, writing of the final report, or the decision to publish
Shaik Department of Biochemistry, Sri Krishnadevaraya University, Anantapur, 515003, Andhra Pradesh, India Popul
Smoking may further amplify these risks, especially when combined with poor diet, alcohol use, obesity, or metabolic disorders